(Presentation) Join Scott Greenlay, MNP’s National Director of Technology Consulting, and Danny Timmins, MNP’s National Cyber Security Leader, as they discuss how going digital will change the cannabis landscape. They’ll discuss Enterprise Resource Planning (ERP) software selection and cyber security – providing meaningful insights on the importance of these two factors and the viability of your cannabis business in today’s market. SPONSORED BY:
(Panel Discussion) - What is expected and what is surprising - What to watch for in the coming months, the challenges and the opportunities - How to “up your game” in relation to compliance issues
Maximizing and Understanding the Benefits of Proprietary Delivery Technologies for Increasing Bioavailability of Cannabinoid Molecules
(Presentation) Davidson will touch on the following delivery routes: Oral – One of the most common route of administration of medicinal cannabis products is via the oral route. Sublingual – Under the tongue. Buccal – Between the cheek and gum bypassing first pass metabolism. Transdermal – through the dermal layer of the skin. Nasal – Direct route bypassing first past metabolism. Encapsulation technologies (Nano,Liposomes,colloidal suspensions) – enhance permeation and bioavailability.
(Presentation) Cannabis science is advancing everywhere from in academia to cannabis QC testing labs and beyond. Join me for an overview and update of current efforts in cannabis science. First, we will distinguish cannabis research from QC testing, and then take a closer look at cannabis research in Israel (with ties to the U.S.). Next, we will examine cannabis research in the U.S., followed by a brief update on international cannabis science. We will cover some current topics in cannabis QC testing, including progress toward cannabis testing standard methods. We will explore the drivers and resistance for standardization and present the main hurdles to both standardization and research. Cannabis medicines have moved from anecdotal evidence [...]
The whole point of legalization is to remove law enforcement from the lives of producers and consumers of cannabis. So now that there is a legal framework, the rest is up to us. This panel will examine the licensing process that exists for medical marijuana and the one that’s shaping up for the recreational side. That license, of course, will be come with conditions, on everything from production practices to handling to distribution to sales. We’ll show you how to stay within the lines of the cannabis regs to come.
(Panel Discussion) The reluctance of banks and other established brokers to take the cannabis market seriously began as an obstacle and turned into opportunity. Players in this new industry have often had to look afield for funding, and in the process have turned to smaller, less risk-averse independent financial brokers to obtain start-up funds. In this session, we’ll talk about the rise of small, forward-thinking investors and other means of revenue-raising in this new, competitive cannabis environment. SPONSORED BY:
(Presentation) People are the greatest asset of many businesses. With Cannabis in the Workplace, the Fair Wages and Better Jobs Act and the #MeTooMovement, workplaces have never found people management as complex and interconnected in the company as it is today. Learn Tips and Strategies on how to navigate the current complexities of Human Resources from an Award Winning HR Expert and Workplace Culture Strategist.
(Presentation) The popularity of hemp-derived CBD products has soared in recent years, with many companies shipping internationally. This panel provides an overview of the laws governing the sale, import, and export of hemp products, and the advertisement of hemp products containing CBD, in four countries: US, Canada, Spain, and Australia.
(Presentation) An important consideration for licensed producers, workers, clinicians, patients, retailers, and policymakers. As the July 2018 marijuana legalization date comes closer, stakeholders in the cannabis industry need to determine how to meet the new demand for skilled workers to fill roles in the growth, production, marketing, and distribution of cannabis. While there's still a giant question mark around how many new jobs the industry will create, the industry is expected to be worth between $5 and 8 billion annually. It’s safe assume that tens of thousands of new Cannabis-related positions will open up with licensed producers, retailers, and in the public sector. An important element affecting industry’s grow and prosperity is access to a [...]
(Presentation) Medical cannabis has proven an effective analgesic for a number of conditions that include chronic non-malignant pain. During Dr.Rosado’s presentation, he will be sharing a case study showing that medical cannabis not only works for analgesia, but also for expected and unexpected medical conditions.